Evidence map›Paper›PMID 33340947›Full record

ArticleThe International journal on drug policy2021

Implementing harm reduction in non-urban communities affected by opioids and polysubstance use: A qualitative study exploring challenges and mitigating strategies.

E Childs, K B Biello, P K Valente, P Salhaney, D L Biancarelli, J Olson, J J Earlywine, B D L Marshall, A R Bazzi

Open access · greenAbstract read
In one paragraph

Article in The International journal on drug policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Brief Report: Availability of Substance Use Services at US HIV Care Facilities by Urbanicity.Journal of acquired immune deficiency syndromes (1999) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

E ChildsAbt Associates, Rockville, MD, USA.
K B BielloCenter for Health Promotion and Health Equity, Brown University, Providence, RI, USA; Department of Behavioral & Social Sciences, Brown University School of Public Health, Providence, RI, USA; Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA; The Fenway Institute, Fenway Health, Boston, MA, USA.
P K ValenteDepartment of Behavioral & Social Sciences, Brown University School of Public Health, Providence, RI, USA.
P SalhaneyCenter for Health Promotion and Health Equity, Brown University, Providence, RI, USA.
D L BiancarelliDepartment of Health Law, Policy & Management, Boston University School of Public Health, Boston, MA, USA.
J OlsonCenter for Health Promotion and Health Equity, Brown University, Providence, RI, USA.
J J EarlywineDepartment of Health Law, Policy & Management, Boston University School of Public Health, Boston, MA, USA; Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA.
B D L MarshallDepartment of Epidemiology, Brown University School of Public Health, Providence, RI, USA.
A R BazziDepartment of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA. Electronic address: abazzi@bu.edu.
Brown University · USBoston University · USAbt Global (United States) · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Efficacy of a community-based PrEP uptake intervention for people who inject drugs in the US NortheastR01DA051849 · NIDA · BROWN UNIVERSITY · PI BAZZI, ANGELA ROBERTSON, BIELLO, KATIE BROOKS · 2020 to 2024
$3.7M
Preventing HIV infection among people who inject drugs during COVID-19K01DA043412 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAZZI, ANGELA ROBERTSON · 2017 to 2021
$934k
NIAID NIH HHS P30 AI042853NIDA NIH HHS K01 DA043412NIDA NIH HHS R01 DA051849
6 · The paper itself

Abstract

backgroundHarm reduction services, which typically provide overdose education and prevention with distribution of naloxone and other supplies related to safer drug use, help reduce opioid-related overdose and infectious disease transmission. However, structural stigma and the ongoing criminalization of drug use have limited the expansion of harm reduction services into many non-urban communities in the United States that have been increasingly affected by the health consequences of opioid and polysubstance use.

methodsWe conducted qualitative interviews with 22 professionals working with people who use drugs in cities and towns across Rhode Island and Massachusetts to understand challenges and strategies for engaging communities in accepting harm reduction perspectives and services.

resultsOur thematic analysis identified several interrelated challenges to implementing harm reduction services in non-urban communities, including: (1) limited understandings of harm reduction practice and preferential focus on substance use treatment and primary prevention, (2) community-level stigma against people who use drugs as well as the agencies supporting them, (3) data reporting and aggregating leading to inaccurate perceptions about local patterns of substance use and related health consequences, and (4) a "prosecutorial mindset" against drug use and harm reduction. From key informants' narratives, we also identified specific strategies that communities could use to address these challenges, including: (1) identifying local champions to advocate for harm reduction strategies, (2) proactively educating communities about harm reduction approaches before they are implemented, (3) improving the visibility of harm reduction services within communities, and (4) obtaining "buy-in" from a wide range of local stakeholders including law enforcement and local government.

conclusionThese findings carry important implications for expanding harm reduction services, including syringe service programs and safe injection sites, into non-urban communities that have a demonstrated need for evidence-based interventions to reduce drug-related overdose and infectious disease transmission.

Indexed as

Analgesics, OpioidDrug OverdoseHarm ReductionHumansMassachusettsRhode IslandAnalgesics, OpioidCommunity researchHarm reductionLaw enforcementQualitative research

Identifiers

PMID33340947
PMCPMC8046716
OpenAlexW3112488505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.